Drug Treatment of Depression in HIV-Positive Patients: Safety Considerations

ISSN： 0114-5916

Source： Drug Safety, Vol.28, Iss.9, 2005-01, pp. : 753-762

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Safety Considerations in Drug Treatment of Depression in HIV-Positive Patients: An Updated Review

By Watkins Crystal C.

Drug Safety, Vol. 34, Iss. 8, 2011-08 ,pp. : 623-639

Adis International

Access to resources Recommend Favorite

A Comparison of the Therapeutic Plan Costs in the Treatment of HIV-Positive Patients

By Sabbatani S.

Clinical Drug Investigation, Vol. 23, Iss. 7, 2003-01 ,pp. : 473-478

Adis International

Access to resources Recommend Favorite

Consider adverse effects and pharmacological interactions when treating depression in HIV-positive patients

By Adis International Limited

Drugs & Therapy Perspectives, Vol. 22, Iss. 6, 2006-06 ,pp. : 9-11

Adis International

Access to resources Recommend Favorite

Drug Treatment for Tuberculosis during Pregnancy: Safety Considerations

By Bothamley G.

Drug Safety, Vol. 24, Iss. 7, 2001-01 ,pp. : 553-565

Adis International

Access to resources Recommend Favorite

Drug Administration in Patients with Diabetes Mellitus: Safety Considerations

By Gilbert R.E.

Drug Safety, Vol. 18, Iss. 6, 1998-06 ,pp. : 441-455

Adis International

Access to resources Recommend Favorite